Patents by Inventor Soraya Allas

Soraya Allas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GH secretagogues and uses thereof
    Patent number: 8481489
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: July 9, 2013
    Assignee: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Alcide Chapdelaine, Soraya Allas, Denis Gravel
  • GH secretagogues and uses thereof
    Patent number: 8435945
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: May 7, 2013
    Assignee: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Alcide Chapdelaine, Soraya Allas, Denis Gravel
  • GH secretagogues and uses thereof
    Patent number: 8314066
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: November 20, 2012
    Assignee: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Alcide Chapdelaine, Soraya Allas, Denis Gravel
  • GH SECRETAGOGUES AND USES THEREOF
    Publication number: 20120004174
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: July 7, 2011
    Publication date: January 5, 2012
    Applicant: THERATECHNOLOGIES INC.
    Inventors: Thierry Abribat, Andre De Villers, Soraya Allas, Denis Gravel, Alcide Chapdelaine
  • SELECTION AND TREATMENT OF PATIENTS SUFFERING FROM WASTING
    Publication number: 20110105390
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
    Type: Application
    Filed: January 11, 2011
    Publication date: May 5, 2011
    Applicant: Theratechnologies Inc.
    Inventors: Bruno LUSSIER, Luc Vachon, Soraya Allas, Thierry Abribat
  • Use of growth hormone releasing factor analogs in treating patients suffering from wasting
    Patent number: 7893025
    Abstract: The present invention provides methods for using growth hormone releasing factor analogs of the formula (A), X-GRF Peptide, and pharmaceutically acceptable salts thereof, for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: February 22, 2011
    Assignee: Theratechnolgies Inc.
    Inventors: Bruno Lussier, Luc Vachon, Soraya Allas, Thierry Abribat
  • GH SECRETAGOGUES AND USES THEREOF
    Publication number: 20100087366
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 8, 2010
    Applicant: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Soraya Allas, Denis Gravel, Alcide Chapdelaine
  • GH SECRETAGOGUES AND USES THEREOF
    Publication number: 20090253623
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: September 26, 2008
    Publication date: October 8, 2009
    Applicant: THERATECHNOLOGIES INC.
    Inventors: THIERRY ABRIBAT, ANDRE DE VILLERS, ALCIDE CHAPDELAINE, SORAYA ALLAS, DENIS GRAVEL
  • GH SECRETAGOGUES AND USES THEREOF
    Publication number: 20090088383
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 2, 2009
    Applicant: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Soraya Allas, Denis Gravel, Alcide Chapdlaine
  • GH SECRETAGOGUES AND USES THEREOF
    Publication number: 20090011985
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: October 23, 2007
    Publication date: January 8, 2009
    Applicant: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Soraya Allas, Denis Gravel, Alcide Chapdelaine
  • Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering From Wasting
    Publication number: 20080167222
    Abstract: The present invention provides methods for using growth hormone releasing factor analogs of the formula (A), X-GRF Peptide, and pharmaceutically acceptable salts thereof, for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
    Type: Application
    Filed: October 20, 2004
    Publication date: July 10, 2008
    Applicant: THERATECHNOLOGIES INC.
    Inventors: Bruno Lussier, Luc Vachon, Soraya Allas, Thierry Abribat
  • GH secretagogues and uses thereof
    Patent number: 7316997
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: January 8, 2008
    Assignee: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre De Villers, Soraya Allas, Denis Gravel, Alcide Chapdelaine
  • GH secretagogues and uses thereof
    Publication number: 20050197288
    Abstract: The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
    Type: Application
    Filed: October 20, 2004
    Publication date: September 8, 2005
    Applicant: Theratechnologies Inc.
    Inventors: Thierry Abribat, Andre Villers, Soraya Allas, Denis Gravel, Alcide Chapdelaine
  • Aframonum seeds for improving penile activity
    Patent number: 5879682
    Abstract: The present invention relates to a pharmaceutical composition for improving penile rigidity and/or preventing erectile dysfunction, including premature ejaculation, of a male mammal patient which comprises at least one of seeds from Aframomum species, its closely related species and remote ancestors thereof, mixture thereof and extracts thereof. The pharmaceutical composition may further comprise a pharmaceutically acceptable carrier for topical or oral administration.
    Type: Grant
    Filed: November 24, 1995
    Date of Patent: March 9, 1999
    Inventors: Soraya Allas, Victor Ngoka, Neil G. Hartman, Simon Owassa, Michel Ibea